Bioventus Inc. BVS
11.02 USD +0.41 (+3.82%)
At closeNov 9, 2026, 4:01 PM EST
11.02 0.00 0.00%
After hours · Nov 9, 4:01 PM ET
10.55 Day range 11.12
6.47 52-week range 15.89
- YTD
- +48.05%
- 1 year
- +47.85%
BVS revenue history
Revenue is income from the company’s ordinary business activities.
568,087,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 568,087,000 | -5,193,000 | -0.91% |
| FY 2024 | 2024-12-31 | 573,280,000 | 60,935,000 | 11.89% |
| FY 2023 | 2023-12-31 | 512,345,000 | 228,000 | 0.04% |
| FY 2022 | 2022-12-31 | 512,117,000 | 81,219,000 | 18.85% |
| FY 2021 | 2021-12-31 | 430,898,000 | 109,737,000 | 34.17% |
| FY 2020 | 2020-12-31 | 321,161,000 | -18,980,000 | -5.58% |
| FY 2019 | 2019-12-31 | 340,141,000 | 20,964,000 | 6.57% |
| FY 2018 | 2018-12-31 | 319,177,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:00:48.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.